(Q40547013)

English

Combination Treatment with Weekly Docetaxel and Gemcitabine for Advanced Non–Small-Cell Lung Cancer in Elderly Patients and Patients with Poor Performance Status: Results of a Minnie Pearl Cancer Research Network Phase II Trial

scientific article published on July 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Combination treatment with weekly docetaxel and gemcitabine for advanced non-small-cell lung cancer in elderly patients and patients with poor performance status: results of a Minnie Pearl Cancer Research Network phase II trial (English)

1 reference

Europe PubMed Central

21 September 2017

Combination Treatment with Weekly Docetaxel and Gemcitabine for Advanced Non–Small-Cell Lung Cancer in Elderly Patients and Patients with Poor Performance Status: Results of a Minnie Pearl Cancer Research Network Phase II Trial (English)

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

John D Hainsworth

1

object named as

John D Hainsworth

1 reference

Europe PubMed Central

21 September 2017

author name string

Minnie Pearl Cancer Research Network

9

1 reference

Europe PubMed Central

21 September 2017

Joan B. Erland

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596701

28 March 2024

John H. Barton

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596701

28 March 2024

Dana S. Thompson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596701

28 March 2024

M. Patrick Stagg

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596701

28 March 2024

James E. Bradof

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596701

28 March 2024

Thomas W. Twele

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596701

28 March 2024

E. Anthony Greco

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596701

28 March 2024

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

21 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S1525730411703187?httpAccept=text/xml

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

https://api.elsevier.com/content/article/PII:S1525730411703187?httpAccept=text/plain

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Clinical Lung Cancer

1 reference

Europe PubMed Central

21 September 2017

5

1 reference

Europe PubMed Central

21 September 2017

1

1 reference

Europe PubMed Central

21 September 2017

33-38

1 reference

Europe PubMed Central

21 September 2017

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

2

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

3

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial

4

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Nonparametric Estimation from Incomplete Observations

6

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Gemcitabine and taxane combinations in non small-cell lung cancer.

7

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma

8

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

12

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma .

13

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer

14

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy

15

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial

16

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

17

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

18

1 reference

10.3816/CLC.2003.N.019

https://api.crossref.org/works/10.3816/CLC.2003.N.019

28 March 2024

Identifiers

10.3816/CLC.2003.N.019

1 reference

https://api.fatcat.wiki/v0/release/uddzd7xikffsdedvnjcnkvvmxy

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_uddzd7xikffsdedvnjcnkvvmxy

1 reference

https://api.fatcat.wiki/v0/release/uddzd7xikffsdedvnjcnkvvmxy

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/uddzd7xikffsdedvnjcnkvvmxy

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40547013&oldid=2112950587"